コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 yl reducing agents activate transcription of cholesterol 7alpha-hydroxylase.
2 of dysfunctional LDL receptors and inhibited cholesterol 7alpha-hydroxylase.
3 etion or the activity of, or mRNA level for, cholesterol 7alpha-hydroxylase.
4 acid pool is the most powerful inhibitor of cholesterol 7alpha-hydroxylase.
5 th the activity of the liver-specific enzyme cholesterol-7alpha-hydroxylase.
6 xpression of the liver-specific gene product cholesterol 7alpha-hydroxylase (7alpha-hydroxylase) was
7 point of this regulation is at the level of cholesterol 7alpha-hydroxylase (7alpha-hydroxylase), whi
8 is initiated in the endoplasmic reticulum by cholesterol 7alpha-hydroxylase, a well studied cytochrom
9 ne day increased hepatic cholesterol 75% and cholesterol 7alpha-hydroxylase activity 1.6 times withou
10 times in NZW rabbits and decreased enhanced cholesterol 7alpha-hydroxylase activity 54%, mRNA levels
11 w studies indicate that genetic variation in cholesterol 7alpha-hydroxylase activity accounts for a s
12 receptor-mediated binding was 26% less, and cholesterol 7alpha-hydroxylase activity and mRNA levels
14 bile acid pool and stimulated downregulated cholesterol 7alpha-hydroxylase activity but did not affe
15 feeding produced 10%-20% increments, whereas cholesterol 7alpha-hydroxylase activity declined progres
17 lglutaryl CoA reductase activity, stimulated cholesterol 7alpha-hydroxylase activity, and enhanced fe
18 ce 7-oxocholesterol is a potent inhibitor of cholesterol 7alpha-hydroxylase, alternative mechanisms f
19 epatic cholesterol does not directly inhibit cholesterol 7alpha-hydroxylase and initially favors enzy
20 macrophage polarization and induced hepatic cholesterol 7alpha-hydroxylase and sterol 12alpha-hydrox
21 key bile acid synthesis proteins, including cholesterol 7alpha-hydroxylase and sterol-27-hydroxylase
23 o bile acid synthetic pathways (classic, via cholesterol 7alpha-hydroxylase, and alternative, via ste
25 f this family, to regulate the expression of cholesterol 7alpha-hydroxylase by means of binding to th
26 he phenotype of the cell (e.g. expression of cholesterol 7alpha-hydroxylase by the liver) may profoun
28 xycholic acid replacement inhibited elevated cholesterol 7alpha-hydroxylase, cholic acid synthesis, a
29 as expression of other FXR targets including cholesterol 7alpha-hydroxylase (Cyp 7a1), sterol 12alpha
31 he accompanying paper that mice deficient in cholesterol 7alpha-hydroxylase (Cyp7-/- mice) exhibit a
32 to induce transcription of the gene encoding cholesterol 7alpha-hydroxylase (Cyp7a), the rate-limitin
35 genes, including the key biosynthetic enzyme cholesterol 7alpha hydroxylase (Cyp7A1) and the bile sal
36 ivated FXR indirectly inhibits expression of cholesterol 7alpha hydroxylase (CYP7A1), a key enzyme in
37 repressed CYP8b1 in the face of induction of cholesterol 7alpha-hydroxylase (CYP7a1 by the new nomenc
39 receptor (VDR) on hepatic activity of human cholesterol 7alpha-hydroxylase (CYP7A1) and cholesterol
41 l BA species in an in vivo model, we created cholesterol 7alpha-hydroxylase (Cyp7a1) and sterol 27-hy
43 port, and metabolism of bile acids including cholesterol 7alpha-hydroxylase (Cyp7a1) and the Na(+)-in
47 hepatic-specific transcription of the human cholesterol 7alpha-hydroxylase (CYP7A1) gene are poorly
48 fetoprotein transcription factor and repress cholesterol 7alpha-hydroxylase (CYP7A1) gene transcripti
50 We recently reported that overexpression of cholesterol 7alpha-hydroxylase (CYP7A1) in the liver res
51 ion of the rate-limiting biosynthetic enzyme cholesterol 7alpha-hydroxylase (CYP7A1) is lost in Cyp8b
56 concentrations of insulin rapidly stimulated cholesterol 7alpha-hydroxylase (CYP7A1) mRNA expression
57 n of sterol 12alpha-hydroxylase (CYP8b1) and cholesterol 7alpha-hydroxylase (CYP7a1) on rates of CA b
58 bit expression of the known SHP target genes cholesterol 7alpha-hydroxylase (CYP7A1) or sterol 12alph
62 liver through transcriptional repression of cholesterol 7alpha-hydroxylase (CYP7A1) via a mechanism
63 ntributes to repression of the gene encoding cholesterol 7alpha-hydroxylase (CYP7A1), a key enzyme fo
64 e "classic" pathway, initiated by microsomal cholesterol 7alpha-hydroxylase (CYP7A1), and an "alterna
65 in a feedback mechanism, repressing hepatic cholesterol 7alpha-hydroxylase (Cyp7a1), the rate-limiti
66 t repress transcription of the gene encoding cholesterol 7alpha-hydroxylase (CYP7A1), the rate-limiti
68 n activate the JNK pathway and down-regulate cholesterol 7alpha-hydroxylase (CYP7A1), the rate-limiti
75 ssociated with specific apolipoprotein E and cholesterol 7alpha-hydroxylase (CYP7A1, rs3808607) genos
76 which acts through hepatic FGFR4 to suppress cholesterol-7alpha hydroxylase (CYP7A1) and limit bile a
77 so displayed decreased expression of hepatic cholesterol-7alpha-hydroxylase (CYP7A1) and sterol 12alp
78 tore the fibroblast growth factor 15 (FGF15)/cholesterol-7alpha-hydroxylase (Cyp7a1) enterohepatic ax
79 ed in the 3'-untranslated region (3'-UTR) of cholesterol-7alpha-hydroxylase (CYP7A1) mRNAs from sever
80 es in the bile acid biosynthesis pathway are cholesterol 7alpha-hydroxylase/CYP7A1 (7alpha-hydroxylas
81 y rat hepatocytes, through inhibition of the cholesterol 7alpha-hydroxylase/CYP7A1 (7alpha-hydroxylas
82 es in the bile acid biosynthetic pathways is cholesterol 7alpha-hydroxylase/cytochrome P450 7alpha-hy
83 , targeted inactivation of the gene encoding cholesterol 7alpha-hydroxylase does not lead to increase
85 se in LXR expression, and a 90% reduction in cholesterol 7alpha-hydroxylase expression in comparison
87 hat mediate bile acid feedback inhibition of cholesterol 7alpha-hydroxylase gene (C YP7A1) transcript
91 idate the mechanism of insulin regulation of cholesterol 7alpha-hydroxylase gene expression in human
93 displayed a significant enhancement of human cholesterol 7alpha-hydroxylase (human [h]CYP7A1; median
97 nd mice indicate that direct manipulation of cholesterol 7alpha-hydroxylase leads to changes in plasm
100 se, dietary cholesterol or colestipol induce cholesterol 7alpha-hydroxylase mRNA levels but do not af
101 ion of hepatic small heterodimer partner and cholesterol-7alpha-hydroxylase mRNA expression, implicat
102 erol metabolism altered by the expression of cholesterol-7alpha-hydroxylase NADPH:oxygen oxidoreducta
103 ffect of transient overexpression of hepatic cholesterol 7alpha-hydroxylase on low density lipoprotei
104 ductase, but it did not change activities of cholesterol 7alpha-hydroxylase or acyl-CoA:cholesterol a
105 igms of cholesterol homeostasis suggest that cholesterol 7alpha-hydroxylase plays a crucial role in s
106 ed human CYP8B1 promoter activities, whereas cholesterol 7alpha-hydroxylase promoter factor (CPF), an
107 ar receptor fetoprotein transcription factor/cholesterol-7alpha-hydroxylase promoter factor (CPF/FTF/
108 ochrome P450 (P450) 7A1 is well known as the cholesterol 7alpha-hydroxylase, the first enzyme involve
109 Cholesterol- and bile acid-controlled liver cholesterol 7alpha-hydroxylase, the limiting enzyme for
110 olelithogenesis by suppressing expression of cholesterol 7alpha-hydroxylase, the rate-limiting enzyme
112 ts was associated with reduced expression of cholesterol 7alpha-hydroxylase, the rate-limiting enzyme
115 lated cholic acid synthesis by up-regulating cholesterol 7alpha-hydroxylase to use cholesterol and re
116 cholesterol- and bile acid-controlled liver cholesterol 7alpha-hydroxylase transcription by FGFR4 an
117 lglutaryl coenzyme A (HMG-CoA) reductase and cholesterol 7alpha-hydroxylase was investigated in 19 Ne
118 ncentrations were reduced significantly when cholesterol 7alpha-hydroxylase was stimulated even in th
121 repressed transcription of the gene encoding cholesterol 7alpha-hydroxylase, which is the rate-limiti
122 nthesis and cellular uptake and induction of cholesterol 7alpha-hydroxylase, which leads to the remov
123 xpression of the liver-specific gene product cholesterol 7alpha-hydroxylase with MTP resulted in leve